SCHEMBL14295174

SCHEMBL14295174

CC(=O)[C@@H](CN1CCSCC1)c1ccc(Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NTSR1 P30989 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.44
▸ HPGD P15428 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.42
▸ BRD4 O60885 1/20 0.41
▸ AKR1C3 P42330 1/20 0.40
▸ PAX8 Q06710 1/20 0.40
▸ SLC6A9 P48067 1/20 0.40
▸ MC4R P32245 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12188342 1.00 NTSR1 (0.46) NTSR1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL12188535 0.87 NTSR1 (0.56) NTSR1ALDH1A1BRD4PAX8SLC6A9
SCHEMBL684408 0.87 NTSR1 (0.56) NTSR1ALDH1A1BRD4PAX8SLC6A9
SCHEMBL12188434 0.87 NTSR1 (0.56) NTSR1ALDH1A1BRD4PAX8SLC6A9
SCHEMBL684723 0.87 NTSR1 (0.59) NTSR1ALDH1A1HPGDBRD4PAX8
SCHEMBL681420 0.86 NTSR1 (0.44) NTSR1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL680738 0.86 NTSR1 (0.44) NTSR1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL8223221 0.86 NTSR1 (0.46) NTSR1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL2738493 0.86 NTSR1 (0.46) NTSR1ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL14288313 0.84 ALDH1A1 (0.48) NTSR1ALDH1A1HPGDBRD4PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9359340-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2016-06-07 — — US disclosed
US-20160152606-A9 HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS GENENTECH, INC. 2016-06-02 — — US disclosed
US-20140349997-A1 HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS ARRAY BIOPHARMA INC (US) 2014-11-27 — — US disclosed
US-8853199-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors ARRAY BIOPHARMA, INC. (US) 2014-10-07 — — US disclosed
US-20080051399-A1 HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS ARRAY BIOPHARMA INC. 2008-02-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051399-A1 HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS AKT1, AKT2, AKT1S1 NTSR1 4515/4885ALDH1A1 1715/4885HPGD 1065/4885
US-20140349997-A1 HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS AKT1, AKT2, AKT1S1 NTSR1 4515/4885ALDH1A1 1715/4885HPGD 1065/4885
US-20160152606-A9 HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS AKT1, AKT2, AKT1S1 NTSR1 4515/4885ALDH1A1 1715/4885HPGD 1065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback